FDA clinical trial
-
豚の腎臓を移植で透析なしで271日過ごした
Biotechnology, eGenesis, end-stage kidney disease, FDA clinical trial, gene-edited pig kidney, Harvard Medical School, immunosuppression, Japan healthcare implications, kidney xenograft, Massachusetts General Hospital, Mike Curtis, organ shortage, pig-to-human organ transplant, porcine organ, regenerative medicine, The Lancet, Tim Andrews, transplant medicine, transplant rejection, UKidney, United Therapeutics, xenograft survival, xenotransplantation
eGenesis社は遺伝子編集された豚腎臓を移植した患者が、その後人間の腎臓移植を受け成功したと発表しました。…
Ken リクルターブログ 